Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic islet transplantation.

P J Morris, D W Gray, R Sutton

    British Medical Bulletin
    |January 1, 1989
    PubMed
    Summary

    Pancreas transplantation can correct Type I diabetes and prevent complications. While whole organ transplants have risks, islet transplantation shows promise, overcoming past technical hurdles for future clinical trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Islet cell transplantation for insulin-dependant diabetes mellitus: perspectives from the present and prospects for the future.

    Expert reviews in molecular medicine·2003
    Same author

    An overview of the immune system with specific reference to membrane encapsulation and islet transplantation.

    Annals of the New York Academy of Sciences·2002
    Same author

    Transplantation of mouse pancreatic islets into primates--in vivo and in vitro evaluation.

    Transplantation·2002
    Same author

    Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.

    The British journal of surgery·2001
    Same author

    Islet transplantation and glucose regulation.

    World journal of surgery·2001
    Same author

    Xenogeneic islets transplanted into primates are subject to a form of hyperacute rejection independent of anti-GAL-alpha 1-->3 gal antibody binding.

    Transplantation proceedings·2001

    Area of Science:

    • Endocrinology
    • Transplantation Immunology
    • Metabolic Diseases

    Background:

    • Type I diabetes (T1D) is characterized by glucose metabolic abnormalities.
    • Microangiopathic complications are a major concern in T1D.
    • Current whole pancreas transplantation is limited by morbidity and immunosuppression needs.

    Purpose of the Study:

    • To evaluate the potential of pancreatic islet transplantation for T1D treatment.
    • To address challenges in islet isolation and transplantation for clinical application.

    Main Methods:

    • Review of current pancreatic transplantation approaches (whole organ vs. islets).
    • Discussion of experimental models (rodents) and challenges (rejection, disease recurrence).
    • Highlighting recent advancements in islet isolation techniques for large mammals.

    Main Results:

    • Rodent studies show islet transplantation corrects experimental diabetes but faces disease recurrence.
    • Allogeneic islet rejection and difficulty in obtaining pure human islets were significant obstacles.
    • Recent technical improvements enable isolation of sufficient numbers of pure islets.

    Conclusions:

    • Islet transplantation, rather than whole organ, is a more viable approach for early-stage T1D.
    • Overcoming rejection and disease recurrence remains critical for successful clinical islet transplantation.
    • Advancements in islet isolation bring clinical trials closer to reality.

    Related Experiment Videos